Eli Lilly Will Sell Zepbound Through Telehealth Company Ro

Eli Lilly Will Sell Zepbound Through Telehealth Company Ro in a Swipe at Legal Copycats
Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the branded drugs, Lilly on Wednesday said it would sell a version of Zepbound through the telemedicine company Ro.
Ro, Eli Lilly to streamline patient access to Zepbound single-dose vials
Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients
Eli Lil­ly has tapped tele­health start­up Ro to dis­trib­ute its sin­gle-dose Zep­bound vials
Through a new relationship with Eli Lilly, Ro patients can now get easier access to the drugmaker’s discounted, single-dose vials of blockbuster obesity drug Zepbound.Ro said Wednesday that it integrated its technology with Lilly’s direct-to-consumer service LillyDirect so that patients can talk to a doctor,
Telehealth firm Ro to provide single-dose vials of Lilly's Zepbound to obesity patients
Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity.
Lilly to sell Zepbound through telehealth platform Ro
Eli Lilly (NYSE:LLY) plans to streamline patient access to its weight-loss drug Zepbound by offering single-dose vials through telehealth platform Ro. The vials will be made available through an integration with Lilly’s (LLY) LillyDirect self-pay pharmacy channel.
NBC Los Angeles20h
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline ...
Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro
By Sneha S K (Reuters) -Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's weight-loss ...
STAT18h
Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s
Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.
pharmaphorum12h
Lilly adds another sales channel for obesity drug Zepbound
"Offering Zepbound single-dose vials…through another platform to LillyDirect will help ensure broader availability of ...
Ro partners with Eli Lilly to expand access to Zepbound vials
Eli Lilly (LLY) has added a new telehealth partner to expand access to single-dose vials of its blockbuster weight loss drug ...
BofA views news of Lilly selling Zepbound through Ro as ‘mixed’ for Hims & Hers
BofA analyst Allen Lutz notes Ro Health, a direct competitor to Hims & Hers (HIMS), announced that the company is working with Eli Lilly ...
btimesonline18h
Eli Lilly Teams with Ro to Expand Access to Lower-Cost Zepbound Vials
Eli Lilly has partnered with direct-to-consumer health-care startup Ro to offer more affordable single-dose vials of its ...
RO WORKS WITH LILLY TO STREAMLINE PATIENT ACCESS TO AUTHENTIC ZEPBOUND® SINGLE-DOSE VIALS BY INTEGRATING WITH LILLY'S PHARMACY CHA…
Ro today announced it is working with Eli Lilly and Company to streamline access to Zepbound® (tirzepatide) single-dose vials ...
STAT19h
Eli Lilly’s new maneuvers in GLP-1 treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is ...